Abstract: The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).

Abstract: The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).

Abstract: The present invention relates to (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine, its salt forms, and to processes for the commercial-scale production of these compounds in sufficient purity and quality for use in pharmaceutical compositions.

Abstract: The present invention relates to (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine, its salt forms, and to processes for the commercial-scale production of these compounds in sufficient purity and quality for use in pharmaceutical compositions.

Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.

Abstract: The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).

Abstract: The present invention relates to (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine, its salt forms, and to processes for the commercial-scale production of these compounds in sufficient purity and quality for use in pharmaceutical compositions.

Abstract: The present invention relates to compounds of formula (I) that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).

Abstract: The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetyl-choline receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).

Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.

Abstract: The invention includes several embodiments of a device for recording electrical activity, particularly the electrical field, from nerve, particularly brain, tissue slices. The device is preferably used for the testing or screening of the effect of physiologically active compounds on the electrical activity of brain tissue slices, which is either electrically evoked or spontaneously occurring. Thus, the invention also includes methods for testing or screening using the device in this manner, for example, to identify compounds that can enhance long term potentiation.

Abstract: For mining combustible minerals a plurality of boreholes are drilled in a gasifiable seam, e.g., in a coal bed, said boreholes 1 through 4 being intercommunicated by a number of gasification ducts. Then the combustible mineral is initiated to fire, and an oxygen-containing blast gas is blown through some of said boreholes into the gasification ducts, with the result that the generator gas is formed. Simultaneously a carbon- and/or hydrogen-containing blast gas is blown through other boreholes situated along the flow of the generator gas to enrich the latter with combustible ingredients. As a result some chemical reactions proceed under the effect of heat produced by the generator gas, whereby additional amounts of combustible elements are formed which add to the calorific value of the generator gas being withdrawn. The method is instrumental also in controlling the composition of the generator gas withdrawn by varying the ratio of the components of the blast gas enriching the generator gas.

Abstract: According to the invention pulverized brown coal is processed by heating brown coal in two stages. During the first stage brown coal being processed is heated by a gaseous heat carrier to a temperature at which thermal decomposition of the brown coal begins. During the second stage the brown coal being processed is heated by the gaseous heat carrier to a temperature at which an intensive thermal decomposition of the brown coal takes place. The stream of the gaseous heat carrier delivered at the second stage of heating is fed with air oxygen and with low-grade products, such as heavy tars and pyrogenic water which are sprayed into the gaseous heat carrier.